| abstract |
Described is the use of compounds of the general formula In n wherein the dotted lines indicate the optional presence of a double bond, R is -(C₁₋₆ alkyl)-OZ or -(C₂₋₆ alkyl)-(OZ)₂ and Z is hydrogen, C₁₋₆ alkyl, phenyl-(C₁₋₄ alkyl), (Y-substituted phenyl)-(C₁₋₄ alkyl), C₁₋₆ alkanoyl, benzoyl or Y-substituted benzoyl wherein Y is methyl, halogen or methoxy, for the preparation of a pharmaceutical composition for inhibiting C₁₇₋₂₀ lyase enzyme and for treating androgen-dependent disorders. |